Extended Data Table 2.
Single-agent lorlatinib treatment-related AEs (A1 and A2)
Treatment-related AEs in at least 10% of patients. Each patient reported once as maximum grade in any course, with attribution possibly, probably and definitely.
Single-agent lorlatinib treatment-related AEs (A1 and A2)
Treatment-related AEs in at least 10% of patients. Each patient reported once as maximum grade in any course, with attribution possibly, probably and definitely.